Book · Julian R. Sterling
ASC 470, ASC 480 and ASC 815-40 for Issuers: Convertible Notes, SAFEs, Warrants, Redeemable Preferred Stock, Debt Modifications and Troubled Debt Restructurings, with IFRS 9 and IAS 32 Comparisons
Every financing leaves two questions on the issuer's desk: is it a liability or equity, and what does it cost through earnings? For one fictional venture-backed company, a term loan with a warrant carries an effective rate of 11.09 percent, a $3,000,000 SAFE and $8,000,000 of convertible notes are carried at fair value, an amendment passes the 10 percent test at 5.20 percent, and a Series B closing brings $40,875,675 of redeemable preferred stock into temporary equity.
The Debt and Equity Accounting Handbook is a practitioner's guide to issuer accounting under ASC 470, ASC 480 and ASC 815-40, with IFRS 9 and IAS 32 compared side by side: the three liability classes of ASC 480, warrants and the indexation and equity classification tests, debt issued with warrants and issuance costs, convertible notes after ASU 2020-06 and the embedded derivative analysis, the fair value option, SAFEs, conversions at a priced round, redeemable preferred stock and temporary equity, earnings per share, covenant breaches and waivers, the 10 percent test for modifications and extinguishments, troubled debt restructurings at the debtor, and the financing file with its memos, controls and disclosures. One company is followed from 1 January 2025 to the end of 2026, and every figure comes from one model.
What you will be able to do:
Sixteen chapters and four appendices: a guide to the companion workbook with twelve exercises, issuer check-lists, questions from the board, the auditors and the interview, and a glossary.
Written for controllers, technical accounting managers, auditors and finance staff of venture-backed and private companies, and for anyone who negotiates financings and has to account for them. The case, its company, its people and its places are fictional, and its figures are teaching assumptions; the standards are paraphrased as read in November 2026. This book is for education only. It is not accounting, legal, tax or investment advice. Part of The Private Markets Career Guides.
How this book was made: written with the help of artificial intelligence tools, under the author's direction; every figure was computed by a model and every rule was checked against its source.
Read next: How do you run the 10 percent test on a debt modification?
Read next: How does the issuer account for warrants issued with a term loan?
Read next: How do you accrete redeemable preferred stock in temporary equity?
The issuer model of the book: a term loan with a liability warrant and its effective interest schedule, the 10 percent test, two troubled debt restructurings, a SAFE and convertible notes at fair value, and the Series B in temporary equity. Live formulas, no macros, nothing locked.
The workbook that rebuilds every figure of the book, free, no sign-up. It allocates the proceeds of the term loan and its warrant, runs the effective interest schedule, the 10 percent test and the two restructurings, values the SAFE and the convertible notes, books the Series B closing and its accretion, and ends with a Checks tab that puts the figures printed in the book beside the cells that compute them.
Appendix A
Tabs: Inputs, Term loan, Amendment, TDR, SAFE, Notes, Series B, Earnings, Checks. With the case typed in, the term loan carries an effective rate of 11.09 percent, the amendment tests at 5.20 percent and the Series B enters temporary equity at $40,875,675.
Download the workbook29 KBRead first
What each tab holds, the case figures to reproduce first, and the conventions behind every number.
Workbook and read-me, one archive26 KB| Term loan | $19,600,000 - $900,000 - $238,520 = $18,461,480: cash received less the warrant at fair value and the costs allocated to the debt, carried at an effective rate of 11.09 percent |
| 10 percent test | $19,893,898 against $18,909,792, both at 10.75 percent: a change of 5.20 percent, below 10 percent, so the amendment is a modification |
| Series B | $24,400,000 + $10,800,000 + $5,675,675 = $40,875,675: new money net of costs, the notes and the SAFE at conversion, in temporary equity |
| Line in earnings | 2025 | 2026 |
| Term loan interest expense | $2,046,619 | $2,271,792 |
| Amendment third-party costs | none | $120,000 |
| Loss on remeasurement of the Series A warrant | $250,000 | $270,000 |
| Third-party costs allocated to the warrant | $11,480 | none |
| Loss on remeasurement of the SAFE | $1,420,000 | $1,255,675 |
| SAFE costs | $30,000 | none |
| Loss on remeasurement of the convertible notes | $1,378,000 | $1,422,000 |
| Convertible note costs | $80,000 | none |
| Total | $5,216,099 | $5,339,467 |
Related titles. The full list is on the author page.
The workbook is provided as it is, without warranty of any kind. Talvenor Robotics, Inc. and its people are fictional; prices, rates, probabilities, valuations and terms are the book’s teaching assumptions, not market norms. Not accounting, legal, tax or investment advice.